The legal basis for the approval of drug advertisements in Lianyungang is: Drug Administration Law of People's Republic of China (PRC), Advertising Law of People's Republic of China (PRC), Interim Measures for the Examination and Management of Drugs, Medical Devices, Health Foods and Formulated Foods for Special Medical Use, Regulations for the Implementation of Drug Administration Law of People's Republic of China (PRC), and so on. On the question of "the legal basis for the approval of drug advertisements in Lianyungang", the following is a detailed answer from Bian Xiao. 1. Lianyungang 1 Legal basis for drug advertisement approval Article 59 of the Drug Administration Law of People's Republic of China (PRC) (revised on 20 19): drug advertisements must be approved by the drug supervision and administration department of the people's government of the province, autonomous region or municipality directly under the Central Government where the enterprise is located, and the drug advertisement approval number shall be issued; Without obtaining the drug advertisement approval number, it shall not be published. 2. Article 46 of the Advertising Law of People's Republic of China (PRC) (20021Revision): Before the advertisements of medical treatment, medicines, medical devices, pesticides, veterinary drugs, health food and other advertisements that should be examined according to laws and administrative regulations are released, the relevant departments (hereinafter referred to as the advertisement examination organs) shall examine the contents of the advertisements; Without review, it shall not be published. 3. Article 5 of the Interim Measures for the Administration of Advertising Examination of Drugs, Medical Devices, Health Foods and Formulated Foods for Special Medical Uses (released on 20 19): The contents of drug advertisements shall be subject to the instructions approved by the State Council Drug Administration. Drug advertisements involving drug names, drug indications or functional indications and pharmacological effects. Shall not exceed the scope of the manual. 4. Article 48 of the Regulations for the Implementation of the Drug Administration Law of People's Republic of China (PRC) (revised on 20 19): When publishing drug advertisements, relevant materials shall be submitted to the drug supervision and administration department of the people's government of the province, autonomous region or municipality directly under the Central Government where the drug production enterprise is located. The pharmaceutical supervisory and administrative departments of the people's governments of provinces, autonomous regions and municipalities directly under the Central Government shall, within 10 working days from the date of receiving the relevant materials, make a decision on whether to issue the approval number of pharmaceutical advertisements; Where the approval number of drug advertisements is issued, it shall be reported to the drug supervision and administration department of the State Council for the record. Two. Materials for examination and approval of drug advertisements in Lianyungang (1) An enterprise applying for publishing drug advertisements shall install a drug advertisement application system and make a drug advertisement examination form in quintuplicate. Among them, the handwriting of the advertising content page should be clear and legible, requiring JPG format and instruction word format. After all items are completed, save → print → submit (export). Samples, TV scripts or broadcast manuscripts must be pasted in the corresponding positions in the form; (2) The applicant uses A4 paper to make and submit the following three sets of materials in corresponding order: 1, and the materials retained by the provincial bureau (the copies of the materials provided shall be stamped with the seal of the holder); (1) cover and catalogue of application materials; (2) 1 drug advertisement review form; (three) the original of the authenticity guarantee (administrative confirmation) of the application materials for administrative license; (4) Letter of commitment from the advertiser; (5) The original power of attorney of the production enterprise as a legal person; (6) A copy of the agent's ID card; (7) A copy of the business license of the pharmaceutical production (operation) enterprise (if there is any change, provide the change materials); (8) A copy of the Pharmaceutical Production (Business) License (if there is any change, change materials shall be provided); (9) a copy of the drug trademark registration certificate (if there is any change, the change materials shall be provided); (10) Copy of drug production approval document (drug registration certificate) (if there is any change, change materials shall be provided); (1 1) copy of drug quality standard; (12) A copy of the instructions audited by the food and drug supervision and administration department (or stamped with the special seal for the record of drug packaging labels of Jiangsu American Food and Drug Administration); (13) unfold the drug sample packaging box (or design draft) and paste it on A4 paper; (14) Instructions (or design drafts) in drug packaging are tiled and pasted on A4 paper; (15) Enterprises involved in the general distribution of drugs in advertising works are required to provide copies of the business license and drug business license of drug trading enterprises (if there are any changes, change materials are required); (16) When handling drug advertisements, advertising companies must provide copies of their business licenses and advertising business licenses; (17) Copies of other certification documents stipulated by laws and regulations, such as registration certificate of over-the-counter drugs, authoritative certification materials related to product characteristics in advertisements, such as textbooks or authoritative magazines (Chinese version), etc. ; (18) If the product name is advertised, a copy of the approval document shall be provided; (19) Electronic file of advertising application: one dda file and one jpg file; (20) TV advertisements should provide RM format files, one advertisement and one file (the name of the manufacturer and the name of the drug should be marked on the outer packaging of the provided electronic or audio-visual materials) (submitted within 2 weeks after finalization); (2 1) broadcast advertisement RM format file, one advertisement and one file (the manufacturer's name and drug name should be marked on the outer packaging of the electronic or audio-visual materials provided) (submitted within 2 weeks after the finalization); (22) The detailed name of the media to be advertised in Jiangsu Province (with the official seal of the enterprise). (23) If the telephone number appears in the advertisement, the proof that the telephone number is owned by the enterprise shall be provided. 2. Jiangsu Administration for Industry and Commerce shall keep the Drug Advertisement Review Form 1 copy (no attachment materials need to be submitted); 3. The enterprise shall keep the Drug Advertisement Examination Form in triplicate (no attachment materials need to be submitted). The above is the answer to the Legal Basis of Drug Advertisement Approval in Lianyungang City. Lianyungang should handle this matter within the scope of advertising law and other laws and regulations. If the content and form of the approved advertising product are inconsistent, it will be investigated and punished according to the illegal drug advertisement. If you have any questions or legal problems, please visit the website for consultation.